Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Clin Immunol ; 43(1): 46-56, 2023 01.
Artigo em Inglês | MEDLINE | ID: mdl-36121535

RESUMO

Almost 2 years into the pandemic and with vaccination of children significantly lagging behind adults, long-term pediatric humoral immune responses to SARS-CoV-2 are understudied. The C19.CHILD Hamburg (COVID-19 Child Health Investigation of Latent Disease) Study is a prospective cohort study designed to identify and follow up children and their household contacts infected in the early 2020 first wave of SARS-CoV-2. We screened 6113 children < 18 years by nasopharyngeal swab-PCR in a low-incidence setting after general lockdown, from May 11 to June 30, 2020. A total of 4657 participants underwent antibody testing. Positive tests were followed up by repeated PCR and serological testing of all household contacts over 6 months. In total, the study identified 67 seropositive children (1.44%); the median time after infection at first presentation was 83 days post-symptom onset (PSO). Follow-up of household contacts showed less than 100% seroprevalence in most families, with higher seroprevalence in families with adult index cases compared to pediatric index cases (OR 1.79, P = 0.047). Most importantly, children showed sustained seroconversion up to 9 months PSO, and serum antibody concentrations persistently surpassed adult levels (ratio serum IgG spike children vs. adults 90 days PSO 1.75, P < 0.001; 180 days 1.38, P = 0.01; 270 days 1.54, P = 0.001). In a low-incidence setting, SARS-CoV-2 infection and humoral immune response present distinct patterns in children including higher antibody levels, and lower seroprevalence in families with pediatric index cases. Children show long-term SARS-CoV-2 antibody responses. These findings are relevant to novel variants with increased disease burden in children, as well as for the planning of age-appropriate vaccination strategies.


Assuntos
Formação de Anticorpos , COVID-19 , Adulto , Humanos , Criança , SARS-CoV-2 , COVID-19/diagnóstico , COVID-19/epidemiologia , Estudos Prospectivos , Estudos Soroepidemiológicos , Controle de Doenças Transmissíveis , Anticorpos Antivirais
2.
Emerg Infect Dis ; 17(12): 2313-5, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22153118

RESUMO

Cardioviruses cause myocarditis and encephalomyelitis in rodents; human cardioviruses have not been ascribed to any disease. We screened 6,854 cerebrospinal fluid and 10 myocardium specimens from children and adults. A genotype 2 cardiovirus was detected from a child who died of sudden infant death syndrome, and 2 untypeable cardioviruses were detected from 2 children with meningitis.


Assuntos
Infecções por Cardiovirus/virologia , Meningite Viral/virologia , Morte Súbita do Lactente/líquido cefalorraquidiano , Adulto , Cardiovirus/classificação , Cardiovirus/genética , Cardiovirus/isolamento & purificação , Infecções por Cardiovirus/líquido cefalorraquidiano , Criança , Estudos de Coortes , Doenças Transmissíveis Emergentes/líquido cefalorraquidiano , Doenças Transmissíveis Emergentes/virologia , Alemanha , Humanos , Lactente , Meningite Viral/líquido cefalorraquidiano , Miocardite/líquido cefalorraquidiano , Miocardite/virologia , Filogenia , RNA Viral/líquido cefalorraquidiano , RNA Viral/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...